Trial Profile
Multiple Sclerosis and Menopause: the effect of hormone replacement therapy on clinical picture and immunology of multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2022
Price :
$35
*
At a glance
- Drugs Estradiol/dydrogesterone (Primary)
- Indications Menopausal syndrome
- Focus Pharmacodynamics
- 03 Nov 2022 Status changed from recruiting to completed.
- 09 Feb 2015 New trial record